Outward Investment by Indian Pharmaceutical and Software Multinational Enterprises: Are the Factors Different?

Vinish Kathuria ()
Additional contact information
Vinish Kathuria: Indian Institute of Technology (IIT) Bombay

Chapter 6 in The Rise of Indian Multinationals, 2010, pp 167-185 from Palgrave Macmillan

Abstract: Abstract The 1990s and early 2000s were a time of strong economic performance and increasing outward foreign direct investment (OFDI) for many developing countries.1 India partook in the growth in both of these areas. One important aspect of Indian OFDI is the dominance of two knowledge-intensive industries—information technology (IT), including software and business process outsourcing, and pharmaceuticals. From a total of 306 foreign acquisitions by Indian multinational enterprises (MNEs) in the period 2000–2006, nearly 50% were in these two industries, with 29.4% from IT, software, and business process outsourcing, and 20.3% from pharmaceuticals and healthcare (Federation of Indian Chambers of Commerce and Industry 2006).2

Keywords: Software Industry; Outward Foreign Direct Investment; Bulk Drug; Indian Firm; Ownership Advantage (search for similar items in EconPapers)
Date: 2010
References: Add references at CitEc
Citations: View citations in EconPapers (1)

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:pal:palchp:978-0-230-11475-3_6

Ordering information: This item can be ordered from
http://www.palgrave.com/9780230114753

DOI: 10.1057/9780230114753_6

Access Statistics for this chapter

More chapters in Palgrave Macmillan Books from Palgrave Macmillan
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().